$1.46 Billion is the total value of Carlyle Group Inc.'s 11 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WAIR | Wesco Aircraft Hldgs Inc | $170,917,000 | -21.3% | 23,096,882 | 0.0% | 11.72% | -14.9% | |
| XBKS | Xenith Bankshares Inc New | $143,434,000 | +4.1% | 4,239,858 | 0.0% | 9.84% | +12.6% | |
| GOGL | Golden Ocean Group Ltd | $88,407,000 | +4.0% | 10,847,447 | 0.0% | 6.06% | +12.4% | |
| SFUN | Fang Hldgs Ltdadr | $68,677,000 | +37.8% | 12,307,691 | 0.0% | 4.71% | +49.0% | |
| CDEV | Centennial Resource Dev Inccl a | $31,353,000 | +10.2% | 1,583,477 | 0.0% | 2.15% | +19.1% | |
| SQBG | Sequential Brnds Group Inc N | $11,338,000 | -40.5% | 6,369,812 | 0.0% | 0.78% | -35.6% | |
| CIEIQ | Cobalt Intl Energy Inc | $2,147,000 | -35.3% | 2,321,525 | 0.0% | 0.15% | -30.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
| Seacor Marine Hldgs Inc | 22 | Q3 2023 | 1.1% |
| Enviva Partners LP | 21 | Q2 2020 | 31.5% |
| Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
| USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
| Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
| Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
| Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
| Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
| Sequential Brnds Group Inc N | 17 | Q1 2020 | 1.7% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Complete Solaria, Inc. | September 22, 2023 | 2,745,879 | 5.7% |
| Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
| Vera Therapeutics, Inc. | August 02, 2023 | 1,872,764 | 4.2% |
| Reneo Pharmaceuticals, Inc. | May 09, 2023 | 2,730,457 | 8.2% |
| EXICURE, INC. | April 13, 2023 | 287,137 | 3.4% |
| SPRUCE BIOSCIENCES, INC. | February 23, 2023 | 3,734,518 | 9.2% |
| Vaxcyte, Inc. | February 10, 2023 | 2,070,724 | 2.6% |
| NuCana plc | August 11, 2022 | 3,353,134 | 6.4% |
| 1Life Healthcare Inc | February 11, 2022 | 13,612,681 | 7.1% |
| Atotech Ltd | February 11, 2022 | 153,672,703 | 78.9% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-05-14 |
| SC 13D/A | 2024-05-13 |
| 10-Q | 2024-05-07 |
| 13F-HR | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.